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Anacin; a brand of aspirin tablets (containing 300mg acetylsalicylic acid), is a widely used analgesics. It is 
recognized as one of the oldest brands of pain reliev rs. Its primary content is acetylsalicylic acid. Here we report a 
case of a 26-year old woman (64 kg in weight and 1.41m in height) who presented with adverse drug reaction 
secondary to Anacin ingestion following gum pain from fish bone injury. About 30mins after ingesting the drug, she 
presented with headache, excessive lacrimal gland secretion and facial swelling. Considering these presentations by 
inference, Anacin may have the potential to cause severe adverse drug reaction in some individuals. Hence, care 
should be taken by doctors, pharmacist and other health care providers when prescribing and monitoring patients 
placed on this medication. Additionally, a detailed history should be taken prior to prescribing and appropriate 
reporting should be made to relevant health authorities when such severe reactions are observed. 
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_____________________________________________________________ 
INTRODUCTION 
Non Steroidal Anti Inflammatory Drugs (NSAIDs) are drugs that provide analgesic and antipyretic (fever reducing) 
effect and in higher doses, anti Inflammatory effect (Warden, 2010; Burke et al., 2006). They are used for painful 
conditions associated with swelling, redness and loss f function of the affected part (Burke et al., 2006; Rossi, 
2006; Green, 2001; Gotzsche, 1989). Some like aspirin and dipyrone also have the power to reduce fever (Bu ke et 
al., 2006). 
 
Anacin; a brand of aspirin tablets containing 300mg acetylsalicylic acid, is the trade name of a widely used 
analgesics sold over the counter (Sanmarkan et al., 2011). Acetylsalicylic acid is used to relieve pain nd bring down 
fever (Burke et al., 2006). It is also used in rheumatism and other conditions of bone pain. It is repo ted that it 
should not be given to children less than one year and should be used with care in asthmatic patients a d all who 
have previously reported difficulty with breathing. 
 
Though rare, adverse drug reactions are reactions triggered by a drug’s active metabolite or by products. 
Specifically, adverse drug reactions are noxious or unintended reactions to a drug that is administered in standard 
doses by the proper route for the purpose of prophylaxis, diagnosis, or treatment of a specific disease 
(Vervloet and Durham, 1998; WHO 1970). Adverse reactions occur in about 5% of patients receiving any drug, and 
0.03% of hospital deaths are believed to be drug-related (Fraser et al., 1999). Considering the fact tha information 
on drug safety is of unquestionable importance (Loke et al., 2006), hence, all adverse drug reactions mu t be 
reported. 
Here we reported a case of a lady who presented with adverse drug reactions secondary to Anacin ingestion. 
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A twenty-six (26) year old lady was referred to thehospital with an hour history of bilateral-periorbital swellings, 
reddish eyes, visual impairment, headache and pains secondary to ingestion of 300mg Anacin, a brand of 
acetylsalicylic acid. 
 
A night earlier, she noticed injury on her gum following an attempt to chew a fish bone. In less than 24 hours, she 
complained of pains in her gum and physical examinatio  revealed no sign of pathology. The patient subsequently 
visited a patent medicine store and was given Anacin (made in Nigeria by SKG-PHARMA Ltd); a drug whose 
indications are headaches, neuralgia, colds, muscular pain and pain following tooth extraction. 
 
She took two tablets and about 25 – 30 minutes after ing stion of the drug, she noticed severe headache nd pains in 
her eyes. Ten (10) minutes later she noticed tearing f om her eyes which were by this time reddish andlater got 
swollen and occluded. Also observed was facial swelling which extended to her cheeks, nose and lips. 
 
She was then rushed to the hospital where she was admitted in the emergency ward and attended to immediat ly by 
the doctor who made a diagnosis of an allergic drug reaction. She was managed with IV Hydrocortison 100mg daily 
for 3 days, IV Genticin 80mg start dose and was placed on Genticin eye drops (2 drops per eye thrice daily for 3 
days) as well as paracetamol tablets and Vitamin C. 
 




Case reports of suspected adverse drug reactions are aid to be common in the medical literature (Aronson et al., 
2002). However, there is paucity of information regarding severe adverse drug reaction from Anacin. By 
implication, these cases are either not reported or left unpublished. According to data published in 2010, there is 
under-reporting of adverse drug reaction in some tertiary health centers in Nigeria (Obodo and Iribhogbe, 2010) as 
well as around the world (Aronson et al., 2002). Adverse drug reaction due to analgesic is implicated in about 1.1% 
of observed adverse drug reaction in some tertiary health centers in Nigeria (Iribhogbe and Agbaje, 2011a). 
Although most of these reactions were observed to be mild to moderate at presentation, however, case reporting 
remains a sine qua none in the post-marketing surveillance of most drugs. 
 
Essentially, type 1 hypersensitivity reaction underlies the adverse reaction to Anacin as presented in this report. This 
is due to IgE priming and massive degranulation of mast cells and basophil accompanied by release of lukotrienes 
and other inflammatory mediators on exposure to the culpable allergen, in this case acetylsalicylic acid (ASA). 
Based on the classification of adverse drug reaction by Rawlin and Thompson (1991), the clinical presentations of 
the patient suggest type B reaction. Additionally, intravenous corticosteroid administration has been found to 
account for 24.1% of clinical management of ADR in patient by resident doctors in Nigeria (Iribhogbe and Agbaje, 
2011b). The case report showed a remarkable improvement in clinical presentation following intravenous 
hydrocortisone therapy. This re-emphasizes the fact that intravenous corticosteroid administration remains the main 
stay of first line therapeutic response to patient with type B adverse drug reactions. 
 
According to Sanmarkan et al., (2011), Anacin contains cetylsalicylic acid plus caffeine. The adverse drug reaction 
reported for acetylsalicylic acids include; gastric upset, hypersensitivity reaction may occur after ingestion of ASA 
by patients with asthma and nasal polyps. In addition, those from caffeine include; disturbing effect of sleep and 
cardiac rhythm in some individual. A withdrawal syndrome characterized by lethargy, irritability and headache has 
been observed in some users. 
 
Although the adverse drug reactions for both contents of Anacin did not include the observed presentations in this 
case, the possible explanation for this case is that the patient’s presentation may be idiosyncratic. 
 
In conclusion, Anacin may be widely used as an analgesic medication. Despite its reported safety, it may have the 
potential to cause excessive lacrimal gland secretion ( earing), periorbital swelling and facial oedema as adverse side 
effects even at the recommended dosages. Thus, Anacin may induce idiosyncratic adverse reaction, hence, health 
care providers should be aware of the potential deleterious effect of Anacin while prescribing same for patients with 
previous history of allergic reactions. 
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